This document is a publication of a patent application filed with the USPTO, specifically application number US20260083796A1. The application, filed on September 26, 2024, by inventor Shil Kothari, describes methods and compositions utilizing the plant Dichrostachys glomerata for therapeutic benefits. These benefits include reducing anxiety, stress, and food cravings, and improving mood, physical health, mental health, energy, and happiness in mammals. The proposed compositions are intended for oral administration in various forms such as pills, capsules, liquids, lozenges, or tablets.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the pharmaceutical and health and wellness sectors. Companies involved in drug discovery, manufacturing, or the development of dietary supplements and therapeutic products should monitor the progress of this patent application and related intellectual property. The CPC classifications indicate relevance to pharmaceutical preparations (A61K 36/48) and general treatment of the central nervous system (A61P 25/00).